These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 17963743

  • 1. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
    Zhu HJ, Wang JS, Donovan JL, Jiang Y, Gibson BB, DeVane CL, Markowitz JS.
    Eur J Pharmacol; 2008 Jan 14; 578(2-3):148-58. PubMed ID: 17963743
    [Abstract] [Full Text] [Related]

  • 2. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep 14; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 3. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, Saito H.
    Biol Pharm Bull; 2009 Sep 14; 32(9):1588-93. PubMed ID: 19721237
    [Abstract] [Full Text] [Related]

  • 4. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
    Iwai M, Minematsu T, Li Q, Iwatsubo T, Usui T.
    Drug Metab Dispos; 2011 Dec 14; 39(12):2314-20. PubMed ID: 21918035
    [Abstract] [Full Text] [Related]

  • 5. Kinetics of doxorubicin handling in the LLC-PK1 kidney epithelial cell line is mediated by both vesicle formation and P-glycoprotein drug transport.
    Crivellato E, Candussio L, Rosati AM, Decorti G, Klugmann FB, Mallardi F.
    Histochem J; 1999 Oct 14; 31(10):635-43. PubMed ID: 10576412
    [Abstract] [Full Text] [Related]

  • 6. Investigation of MDR1-overexpressing cell lines to derive a quantitative prediction approach for brain disposition using in vitro efflux activities.
    Sato S, Tohyama K, Kosugi Y.
    Eur J Pharm Sci; 2020 Jan 15; 142():105119. PubMed ID: 31682973
    [Abstract] [Full Text] [Related]

  • 7. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 1999 Dec 15; 90(12):1380-6. PubMed ID: 10665657
    [Abstract] [Full Text] [Related]

  • 8. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
    Kuteykin-Teplyakov K, Luna-Tortós C, Ambroziak K, Löscher W.
    Br J Pharmacol; 2010 Jul 15; 160(6):1453-63. PubMed ID: 20590635
    [Abstract] [Full Text] [Related]

  • 9. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum.
    Smith AJ, Mayer U, Schinkel AH, Borst P.
    J Natl Cancer Inst; 1998 Aug 05; 90(15):1161-6. PubMed ID: 9701366
    [Abstract] [Full Text] [Related]

  • 10. Effect of ADHD medication in male C57BL/6J mice performing the rodent Continuous Performance Test.
    Caballero-Puntiverio M, Lerdrup LS, Grupe M, Larsen CW, Dietz AG, Andreasen JT.
    Psychopharmacology (Berl); 2019 Jun 05; 236(6):1839-1851. PubMed ID: 30656365
    [Abstract] [Full Text] [Related]

  • 11. Is aspirin a substrate of MDR1/P-glycoprotein?
    Singh R, Naik T, Nigam A, Chatterjee S, Rajanna P, Shen H, Iyer R.
    Xenobiotica; 2020 Oct 05; 50(10):1258-1264. PubMed ID: 32302241
    [Abstract] [Full Text] [Related]

  • 12. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
    Tanaka K, Hirai M, Tanigawara Y, Ueda K, Takano M, Hori R, Inui K.
    Biochem Pharmacol; 1997 Mar 07; 53(5):741-6. PubMed ID: 9113094
    [Abstract] [Full Text] [Related]

  • 13. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.
    Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y.
    Drug Metab Pharmacokinet; 2008 Mar 07; 23(5):340-6. PubMed ID: 18974611
    [Abstract] [Full Text] [Related]

  • 14. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions.
    Muenster U, Grieshop B, Ickenroth K, Gnoth MJ.
    Pharm Res; 2008 Oct 07; 25(10):2320-6. PubMed ID: 18523872
    [Abstract] [Full Text] [Related]

  • 15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 07; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 16. Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).
    Florea BI, van der Sandt IC, Schrier SM, Kooiman K, Deryckere K, de Boer AG, Junginger HE, Borchard G.
    Br J Pharmacol; 2001 Dec 07; 134(7):1555-63. PubMed ID: 11724763
    [Abstract] [Full Text] [Related]

  • 17. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD.
    AIDS; 2001 Mar 09; 15(4):483-91. PubMed ID: 11242145
    [Abstract] [Full Text] [Related]

  • 18. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
    Wang R, Sun X, Deng YS, Qiu XW.
    Xenobiotica; 2019 Nov 09; 49(11):1373-1378. PubMed ID: 30587068
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells.
    Takara K, Tsujimoto M, Kokufu M, Ohnishi N, Yokoyama T.
    Biol Pharm Bull; 2003 Feb 09; 26(2):205-9. PubMed ID: 12576681
    [Abstract] [Full Text] [Related]

  • 20. Using the test of variables of attention to determine the effectiveness of modafinil in children with attention-deficit hyperactivity disorder (ADHD): a prospective methylphenidate-controlled trial.
    Goez HR, Scott O, Nevo N, Bennett-Back O, Zelnik N.
    J Child Neurol; 2012 Dec 09; 27(12):1547-52. PubMed ID: 22447850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.